Resistance mechanism to an uncompetitive inhibitor of a single-substrate, single-product enzyme: a study of Helicobacter pylori glutamate racemase

作者: Thomas A Keating

DOI: 10.4155/FMC.13.94

关键词: PeptidoglycanMutantGlutamate racemaseEnzymeGlutamate receptorUncompetitive inhibitorSubstrate (chemistry)BiochemistryMuriBiology

摘要: Two independent series of inhibitors Helicobacter pylori glutamate racemase (MurI) were characterized for their kinetic mechanism, and one was used to generate resistant mutants in vitro. Mutant MurI enzymes from these strains by structural, genetic, biophysical methods. Both inhibitor series, pyrazolopyrimidinediones benzodiazepines, are uncompetitive with respect the substrate, resistance mutations found act reducing affinity thereby pool enzyme–substrate complex available binding inhibitor, while still allowing sufficient activity peptidoglycan construction. Uncompetitive a single-substrate, single-product enzyme rare, this work gives insight into an remarkable mechanism. This article will discuss projected clinical impact H. on types inhibitors.

参考文章(37)
P Doublet, J van Heijenoort, J P Bohin, D Mengin-Lecreulx, The murI gene of Escherichia coli is an essential gene that encodes a glutamate racemase activity. Journal of Bacteriology. ,vol. 175, pp. 2970- 2979 ,(1993) , 10.1128/JB.175.10.2970-2979.1993
B. L. Staker, K. Hjerrild, M. D. Feese, C. A. Behnke, A. B. Burgin, L. Stewart, The mechanism of topoisomerase I poisoning by a camptothecin analog Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 15387- 15392 ,(2002) , 10.1073/PNAS.242259599
David J. Payne, Michael N. Gwynn, David J. Holmes, David L. Pompliano, Drugs for bad bugs: confronting the challenges of antibacterial discovery Nature Reviews Drug Discovery. ,vol. 6, pp. 29- 40 ,(2007) , 10.1038/NRD2201
Kathleen A. Gallo, Martin E. Tanner, Jeremy R. Knowles, Mechanism of the reaction catalyzed by glutamate racemase. Biochemistry. ,vol. 32, pp. 3991- 3997 ,(1993) , 10.1021/BI00066A020
Seng-Kee Chuah, A new look at anti-Helicobacter pylori therapy World Journal of Gastroenterology. ,vol. 17, pp. 3971- 3975 ,(2011) , 10.3748/WJG.V17.I35.3971
Megan J Duckworth, Arinze S Okoli, George L Mendz, Novel Helicobacter pylori therapeutic targets: The unusual suspects Expert Review of Anti-infective Therapy. ,vol. 7, pp. 835- 867 ,(2009) , 10.1586/ERI.09.61
Daniel J Krosky, Richard Alm, Mikael Berg, Gilles Carmel, Peter J Tummino, Bo Xu, Wei Yang, Helicobacter pylori 3-deoxy-D-manno-octulosonate-8-phosphate (KDO-8-P) synthase is a zinc-metalloenzyme. Biochimica et Biophysica Acta. ,vol. 1594, pp. 297- 306 ,(2002) , 10.1016/S0167-4838(01)00319-3
Bolin Geng, Gregory Basarab, Janelle Comita-Prevoir, Madhusudhan Gowravaram, Pamela Hill, Andrew Kiely, James Loch, Lawrence MacPherson, Marshall Morningstar, George Mullen, Ekundayo Osimboni, Alexander Satz, Charles Eyermann, Tomas Lundqvist, Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines. Bioorganic & Medicinal Chemistry Letters. ,vol. 19, pp. 930- 936 ,(2009) , 10.1016/J.BMCL.2008.11.113
Tomas Lundqvist, Stewart L. Fisher, Gunther Kern, Rutger H. A. Folmer, Yafeng Xue, D. Trevor Newton, Thomas A. Keating, Richard A. Alm, Boudewijn L. M. de Jonge, Exploitation of Structural and Regulatory Diversity in Glutamate Racemases Nature. ,vol. 447, pp. 817- 822 ,(2007) , 10.1038/NATURE05689